MetLife Investment Management LLC Sells 2,675 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

MetLife Investment Management LLC cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.4% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 108,302 shares of the medical equipment provider’s stock after selling 2,675 shares during the quarter. MetLife Investment Management LLC’s holdings in Intuitive Surgical were worth $53,206,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Creekmur Asset Management LLC grew its holdings in shares of Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares in the last quarter. LRI Investments LLC bought a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of recent research reports. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Mizuho raised their price target on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. JPMorgan Chase & Co. lifted their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Royal Bank of Canada upped their target price on shares of Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Raymond James lifted their price target on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $526.06.

Intuitive Surgical Price Performance

Shares of ISRG traded down $0.73 during mid-day trading on Wednesday, hitting $541.37. 38,018 shares of the company’s stock were exchanged, compared to its average volume of 1,451,329. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The company has a 50-day simple moving average of $506.81 and a 200 day simple moving average of $466.29. The company has a market cap of $192.83 billion, a PE ratio of 87.15, a P/E/G ratio of 5.28 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 2,128 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. This trade represents a 88.63 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Gary Loeb sold 300 shares of the company’s stock in a transaction dated Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the transaction, the general counsel now owns 1,595 shares in the company, valued at approximately $757,625. This trade represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 50,647 shares of company stock worth $26,170,907. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.